Measuring the global response to antimicrobial resistance, 2020–21: a systematic governance analysis of 114 countries
Patel J, Harant A, Fernandes G, et al.
16 Jan 2023
Access via The Lancet
Following the publication of the Global Action Plan against antimicrobial resistance in 2015, countries were tasked with the development of National Action Plans, or NAPs. NAPs summarize country strategic plans to build and strengthen antimicrobial surveillance capacity in all sectors and long-lasting political commitment to control the spread of AMR through specific policies to promote antimicrobial stewardship, community participation and awareness. This paper was aimed at assessing NAPs using a governance framework to characterize the global response to AMR and its progress over the last seven years. The authors identified disparities in governance and AMR national efforts.
Who this is for
- Policy makers
- Public health professionals
- 114 NAPs were selected as eligible and analyzed in this study.
- The analysis identified a strong commitment from countries to develop and implement activities and policies to tackle AMR, however plans to monitor and evaluate the effectiveness and sustainability of interventions were lacking.
- Financing of AMR activities was found to be a major challenge in all countries.
- Equity and accessibility to healthcare and medicines was reflected as a major issue, especially in low and middle-income countries.
- The number of NAPs developed should not be used as a standard to assess progress towards meeting AMR goals.
- Despite commitment from 194 countries, records of NAPs for 72 countries were missing. The authors recognize plans might exist and are awaiting to be published.